HMGB1 and Alzheimer disease: Increased levels of endogenous HMGB1 have also been detected in neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and multiple sclerosis, contributing to chronic neurodegeneration and progression of neuroinflammation [73].